Cobe Labs
This article was originally published in The Gray Sheet
Executive Summary
Gambro unit receives FDA clearance for the Trima automated blood component collection system, the firm reports Feb. 11. An alternative to whole blood collections, the system is the "first device to allow blood centers to collect combinations of red blood cells, platelets, and plasma simultaneously from a single blood donor," the company says. By collecting the blood products from the same donor, the Trima system yields "more transfusable products per donation than conventional whole blood collection"
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.